Our approach in such cases involves a combination of thorough legal strategizing and deep pharmaceutical knowledge, enabling us to effectively represent clients who have experienced adverse effects from these medications
While randomized controlled trials offer rigorous evidence, they may not fully represent older, multimorbid, or polytreated patients seen in primary care
[6,7] GLP-1 receptor agonist medications may cause some side effects, which vary depending on the individual
The SELECT trial, published in 2024, showed that semaglutide reduced major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) by 20% in individuals with obesity, even independent of weight loss magnitude. Why
Con la semaglutida oral estas cifras fueron el 19, el 20, el 24 y el 21% respectivamente
Always keep your healthcare provider informed and use trusted resources like Doctronic.ai for personalized, expert advice